Abingdon Health PLC (AIM:ABDX) Judicial Review – judgement expected

York, U.K. 7 October 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high-quality and effective rapid tests, notes that a judgement in relation to the Judicial Review proceedings initiated by the Good Law Project Limited (“GLP”) against the Department of Health and Social Care (“DHSC”) is expected to be handed down today at 12noon.

Abingdon Health is an interested party in the case.

Details are provided in section 17.4 of this link:


A further announcement will be made once the outcome of the Judicial Review is known.


Abingdon Health plc


Chris Yates, Chief Executive Officer

Via Walbrook PR

Melanie Ross , Chief Financial Officer

Chris Hand, Non-Executive Chairman

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.